Sushil Patel
Director; Director, Chief Executive Officer · 4 filings · Latest: Jun 29, 2026
Replimune Group, Inc.
Revolution Medicines, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RVMD | Sushil Patel | Director | Jun 29, 2026 | Sale | $187.99 | 5,580 | $1.0M | 21,656 | |
RVMD | Sushil Patel | Director | Jun 29, 2026 | Option Exercise | $37.54 | 2,955 | $110.9K | 27,236 | |
RVMD | SUSHIL PATEL | — | Jun 29, 2026 | Proposed Sale | $182.08 | 5,580 | $1.0M | — | |
REPL | Sushil Patel | Director, Chief Executive Officer | May 18, 2026 | Sale | $5.08 | 37,324 | $189.6K | 747,492 | |
REPL | Sushil Patel | — | Dec 2, 2025 | Proposed Sale | $11.13 | 10,000 | $111.3K | — | |
REPL | Sushil Patel | — | Dec 16, 2024 | Proposed Sale | $12.57 | 15,000 | $188.6K | — | |
RVMD | SUSHIL PATEL | — | Oct 31, 2024 | Proposed Sale | $50.50 | 5,000 | $252.5K | — |